BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36174955)

  • 1. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
    Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
    J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
    Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
    Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted serum metabolic profiling of colorectal cancer progression.
    Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
    Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
    Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
    Clin Chim Acta; 2024 May; 560():119732. PubMed ID: 38772522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
    Li G; Zhao D; Peng X; Zhao Y
    Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
    Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
    Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
    Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of dimethylated nucleosides in serum from colorectal cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Cao X; Wang M; Huang Y; Zhang M; Zheng F; Zhang G; Su J; Yuan Y; Guo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123973. PubMed ID: 38142502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.
    Kohoutova D; Smajs D; Moravkova P; Cyrany J; Moravkova M; Forstlova M; Cihak M; Rejchrt S; Bures J
    BMC Infect Dis; 2014 Dec; 14():733. PubMed ID: 25540872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S; Mohammadiasl J; Mokarram P
    Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men.
    Yagi M; Sasaki Y; Abe Y; Yaoita T; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kon T; Nishise S; Ueno Y
    Digestion; 2020; 101(5):571-578. PubMed ID: 31269491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry.
    Sun L; Kang Q; Pan Y; Li N; Wang X; He Y; Wang H; Yu D; Xie H; Yang L; Lu Y; Jin P; Sheng J
    Cancer Biol Ther; 2019; 20(7):1017-1028. PubMed ID: 30983515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009.
    Chen HM; Weng YR; Jiang B; Sheng JQ; Zheng P; Yu CG; Fang JY
    J Dig Dis; 2011 Oct; 12(5):371-8. PubMed ID: 21955430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.